About the job

Sanofi has decided to invest into a new large state-of-the art facility for Insulin Drug Substance in Beijing, China. For this green field operation, we’re enhancing our legacy of excellence and build on decades of expertise on the whole value chain of insulin manufacturing. The new facility will be designed as a fully automated, green, modern, and state-of-the-art biologics facility. A large global and highly cross-functional program organization will be established to lead and execute the program until commercial routine manufacturing.

Meet Katrin, our Global Program Leader, and discover how we’re transforming insulin production.

Main responsibilities

Please indicate here the main job responsibilities

During Project stage

· Collaborate strongly with IFF Program teams to Manage all insulin downstream process systems (DSP) maintenance activities (e.g., chromatography, crystallization, drying) from Basic Engineering to ...